Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA To Improve Early Pediatric Advice Initiative

Executive Summary

The European Medicines Agency is to fine tune its early interaction initiative to help companies shape their pediatric development plans alongside programs for adults.

You may also be interested in...



‘Not What We Expected,’ R&D Industry Says Of ‘Onerous’ EU Paediatric Regulation

The research-based drug industry has not minced its words in describing the problems it has faced from the EU Paediatric Regulation over the past 10 years.

EMA's Early Pediatric Advice Pilot Has Mixed Results

Agency provides early advice on pediatric development to only a handful of applications thus far.

EMA Pilot For Early Advice On Pediatric Research Finally Gets Going

EMA has gotten applications from sponsors for early advice on developing medicines for pediatric indications, under one-year pilot project.

Topics

UsernamePublicRestriction

Register

PS120845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel